The Nucleocapsid Protein Of SARS-CoV-2, Combined With ODN-39M, Is A Potential Component For An Intranasal Bivalent Pancorona Vaccine
Y. Lobaina, R. Chen, E. Suzarte, P. Ai, V. Huerta, A. Musacchio, R. Silva, C. Tan, A. Martin, L. Lazo, G. Guillen, K. Yang, Y. Perera, L. Hermida
This paper evaluates a bivalent intranasal vaccine candidate combining SARS-CoV-2 N protein and ODN-39M, showing cross-reactive immunity against SARS-CoV-1 and enhanced Th1 response when combined with RBD.
bioRxiv · Jun 2, 2022 · PreprintImmunology